PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche.

Papi, Alessio

PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche. [electronic resource] - Journal of cellular physiology Nov 2014 - 1595-606 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1097-4652

10.1002/jcp.24601 doi


Antigens, Neoplasm--metabolism
Apolipoproteins E--metabolism
Biomarkers, Tumor--metabolism
Breast Neoplasms--enzymology
Carbonic Anhydrase IX
Carbonic Anhydrases--metabolism
Cell Hypoxia--drug effects
Cell Survival--drug effects
Exosomes--drug effects
Female
Fibroblasts--drug effects
Humans
Hypoxia-Inducible Factor 1, alpha Subunit--metabolism
Inflammation--metabolism
Ligands
MCF-7 Cells
Matrix Metalloproteinase 9--metabolism
Models, Biological
NF-kappa B--metabolism
Neoplastic Stem Cells--drug effects
PPAR gamma--metabolism
Phenanthrenes--pharmacology
Pioglitazone
Receptor Cross-Talk--drug effects
Retinoid X Receptors--agonists
Spheroids, Cellular--drug effects
Stem Cell Niche--drug effects
Stromal Cells--drug effects
Thiazolidinediones--pharmacology